LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL

Autor: Mirta Giordano, Guillermo Dighiero, Angimar Uriepero, Thaïs Souto-Padrón, Victoria Irigoin, Raul Gabus, Cecilia Guillermo, Noé Seija, Pablo Oppezzo, Daniel Prieto, Carolina Oliver, Marcelo A. Navarrete, Ana Inés Landoni
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
CIENCIAS MÉDICAS Y DE LA SALUD
Inmunología
Endogeny
Biology
Gene Expression Regulation
Enzymologic

Flow cytometry
03 medical and health sciences
0302 clinical medicine
IGHV PROFILE
immune system diseases
hemic and lymphatic diseases
Biomarkers
Tumor

Extracellular
medicine
PROGNOSTIC MARKER
Humans
RNA
Messenger

RNA
Neoplasm

Aged
Messenger RNA
Lipoprotein lipase
medicine.diagnostic_test
Gene Expression Regulation
Leukemic

digestive
oral
and skin physiology

nutritional and metabolic diseases
Hematology
purl.org/becyt/ford/3.1 [https]
Middle Aged
Prognosis
Subcellular localization
Leukemia
Lymphocytic
Chronic
B-Cell

Neoplasm Proteins
Lipoprotein Lipase
Medicina Básica
CHRONIC LYMPHOCYTIC LEUKAEMIA
030220 oncology & carcinogenesis
FLOW CYTOMETRY
Cancer research
biology.protein
Female
lipids (amino acids
peptides
and proteins)

purl.org/becyt/ford/3 [https]
Antibody
LPL
IGHV@
030215 immunology
Zdroj: CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
DOI: 10.1111/bjh.15427
Popis: Lipoprotein lipase (LPL) mRNA expression in chronic lymphocytic leukaemia (CLL) is associated with an unmutated immunoglobulin profile and poor clinical outcome. We evaluated the subcellular localization of LPL protein in CLL cells that did or did not express LPL mRNA. Our results show that LPL protein is differently located in CLL cells depending on whether it is incorporated from the extracellular medium in mutated CLL or generated de novo by leukaemic cells of unmutated patients. The specific quantification of endogenous LPL protein correlates with mRNA expression levels and mutational IGHV status, suggesting LPL protein as a possible reliable prognostic marker in CLL. Fil: Prieto, Daniel. Instituto Pasteur de Montevideo; Uruguay. Instituto de Investigaciones Biológicas "Clemente Estable"; Uruguay Fil: Seija, Noé. Universidad de la República; Uruguay. Instituto Pasteur de Montevideo; Uruguay Fil: Uriepero, Angimar. Instituto Pasteur de Montevideo; Uruguay Fil: Souto-Padron, Thais. Universidade Federal do Rio de Janeiro; Brasil Fil: Oliver, Carolina. Universidad de la República; Uruguay Fil: Irigoin, Victoria. Universidad de la República; Uruguay Fil: Guillermo, Cecilia. Universidad de la República; Uruguay Fil: Navarrete, Marcelo A.. Universidad de Magallanes; Chile Fil: Inés Landoni, Ana. Ministerio de Salud. Administración Servicios de Salud del Estado. Hospital Maciel; Uruguay Fil: Dighiero, Guillermo. Ministerio de Salud. Administración Servicios de Salud del Estado. Hospital Maciel; Uruguay Fil: Gabus, Raúl. Ministerio de Salud. Administración Servicios de Salud del Estado. Hospital Maciel; Uruguay Fil: Giordano, Mirta Nilda. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Oppezzo, Pablo. Instituto Pasteur de Montevideo; Uruguay
Databáze: OpenAIRE